✦ LIBER ✦

Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan

✍ Scribed by Victor H. Monterroso; Victor Rodriguez Chavez; Evert T. Carbajal; Daniel R. Vogel; Gustavo J. Aroca Martinez; Luis H. Garcia; Jorge H. B. Cuevas; Joffre LaraTeran; Gerhart Hitzenberger; Pedro Leao Neves; Shirley J. Middlemost; Thomas Dumortier; Antonius M. G. Bunt; Ronald D. Smith

Publisher: Springer Healthcare Communications
Year: 2000
Tongue: English
Weight: 175 KB
Volume: 17
Category: Article
ISSN: 0741-238X
DOI: 10.1007/bf02854844

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valsartan, a new angiotensin II antagoni

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide

✍ G. Hegner; G. Faust; F. Freytag; S. Meilenbrock; J. Sullivan; F. Bodin 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 92 KB

Comparative efficacy of valsartan and ol

Comparative efficacy of valsartan and olmesartan in mild-to-moderate hypertension: Results of 24-hour ambulatory blood pressure monitoring

✍ Maurizio Destro; Rossana Scabrosetti; Alessandro Vanasia; Amedeo Mugellini 📂 Article 📅 2005 🏛 Springer Healthcare Communications 🌐 English ⚖ 465 KB